Economic aspects of the cardiology program expansion of additional drugs provision by effective lipidlowering drugs for hypercholesterolemia control

• Main Authors: O. V. Obuhova (Author), A. S. Bogomazova (Author), A. N. Meshkov (Author), M. V. Ezhov (Author)
• Formato: Libro
• Publicado: Izdatelstvo OKI, 2024-02-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

The federal program of preferential drug provision in cardiology shows its effectiveness. However, hypercholesterolemia (HCH) remains a significant problem in patients in whom high-dose statin therapy does not provide the target level of low-density lipoprotein cholesterol (LDL cholesterol). The sol...